201 related articles for article (PubMed ID: 9524295)
1. Reactivity of chagasic antigal antibodies with noninfected cells treated with Trypanosoma cruzi secreted/excreted antigens.
Yokoyama-Yasunaka JK; Piazza RM; Umezawa ES; Stolf AM
J Clin Lab Anal; 1998; 12(2):108-14. PubMed ID: 9524295
[TBL] [Abstract][Full Text] [Related]
2. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies.
Almeida IC; Milani SR; Gorin PA; Travassos LR
J Immunol; 1991 Apr; 146(7):2394-400. PubMed ID: 1706399
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a natural human antibody with anti-galactosyl(alpha 1-2)galactose specificity that is present at high titers in chronic Trypanosoma cruzi infection.
Avila JL; Rojas M; Velazquez-Avila G
Am J Trop Med Hyg; 1992 Oct; 47(4):413-21. PubMed ID: 1279994
[TBL] [Abstract][Full Text] [Related]
4. Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi.
Almeida IC; Ferguson MA; Schenkman S; Travassos LR
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):793-802. PubMed ID: 7818483
[TBL] [Abstract][Full Text] [Related]
5. GPI-anchored glycoconjugates from Trypanosoma cruzi trypomastigotes are recognized by lytic anti-alpha-galactosyl antibodies isolated from patients with chronic Chagas' disease.
Almeida IC; Ferguson MA; Schenkman S; Travassos LR
Braz J Med Biol Res; 1994 Feb; 27(2):443-7. PubMed ID: 8081263
[TBL] [Abstract][Full Text] [Related]
6. Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies.
Gazzinelli RT; Pereira ME; Romanha A; Gazzinelli G; Brener Z
Parasite Immunol; 1991 Jul; 13(4):345-56. PubMed ID: 1717927
[TBL] [Abstract][Full Text] [Related]
7. [Levels of anti-Gal antibodies in persons infected and non-infected with Trypanosoma cruzi. Probably induced by bacteria and by the parasite].
González J; Ramírez C; Seguel X; Gutiérrez B; Manque P; Porcile P; Neira I; Sagua H
Bol Chil Parasitol; 1995; 50(1-2):3-9. PubMed ID: 8573266
[TBL] [Abstract][Full Text] [Related]
8. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease.
Laucella SA; de Titto EH; Segura EL
Acta Trop; 1996 Dec; 62(3):151-62. PubMed ID: 9025983
[TBL] [Abstract][Full Text] [Related]
9. Use of Trypanosoma cruzi purified glycoprotein (GP57/51) or trypomastigote-shed antigens to assess cure for human Chagas' disease.
Gazzinelli RT; Galvao LM; Krautz G; Lima PC; Cancado JR; Scharfstein J; Krettli AU
Am J Trop Med Hyg; 1993 Nov; 49(5):625-35. PubMed ID: 8250103
[TBL] [Abstract][Full Text] [Related]
10. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
Umezawa ES; Shikanai-Yasuda MA; Stolf AM
J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-linked immunosorbent assay with Trypanosoma cruzi excreted-secreted antigens (TESA-ELISA) for serodiagnosis of acute and chronic Chagas' disease.
Umezawa ES; Nascimento MS; Stolf AM
Diagn Microbiol Infect Dis; 2001 Mar; 39(3):169-76. PubMed ID: 11337184
[TBL] [Abstract][Full Text] [Related]
12. Comparison of chagasic and non-chagasic myocardiopathies by ELISA and immunoblotting with antigens of Trypanosoma cruzi and Trypanosoma rangeli.
O'Daly JA; Carrasco H; Fernandez V; Rodríguez MB
Acta Trop; 1994 Apr; 56(4):265-87. PubMed ID: 8023751
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to T. cruzi cytosol acidic antigens (FIV) in Chagas' disease recognize parasite cell surface and human heart epitopes.
Gea S; Gruppi A; Basso B; Menso E; Vottero-Cima E
J Clin Lab Immunol; 1990 Apr; 31(4):183-7. PubMed ID: 1726727
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag163B6).
Malchiodi EL; Chiaramonte MG; Taranto NJ; Zwirner NW; Margni RA
Clin Exp Immunol; 1994 Sep; 97(3):417-23. PubMed ID: 8082296
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Trypanosoma cruzi antigens recognized by sera from patients with chronic Chagas' disease.
Gea S; Rodriguez P; Vottero-Cima E
Int Arch Allergy Appl Immunol; 1987; 84(4):410-3. PubMed ID: 3119504
[TBL] [Abstract][Full Text] [Related]
16. Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease.
Umezawa ES; Nascimento MS; Kesper N; Coura JR; Borges-Pereira J; Junqueira AC; Camargo ME
J Clin Microbiol; 1996 Sep; 34(9):2143-7. PubMed ID: 8862574
[TBL] [Abstract][Full Text] [Related]
17. Chagas' disease: polyspecificity of antibodies against Trypanosoma cruzi acidic antigens.
Ordoñez P; Gea S; Iosa D; Vottero-Cima E
Acta Trop; 1995 May; 59(2):93-103. PubMed ID: 7676911
[TBL] [Abstract][Full Text] [Related]
18. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage.
Di Noia JM; Buscaglia CA; De Marchi CR; Almeida IC; Frasch AC
J Exp Med; 2002 Feb; 195(4):401-13. PubMed ID: 11854354
[TBL] [Abstract][Full Text] [Related]
19. Molecular mimicry between Trypanosoma cruzi and host nervous tissues.
Avila JL
Acta Cient Venez; 1992; 43(6):330-40. PubMed ID: 1343745
[TBL] [Abstract][Full Text] [Related]
20. Anti-alpha-galactosyl antibodies in chagasic patients. Possible biological significance.
Milani SR; Travassos LR
Braz J Med Biol Res; 1988; 21(6):1275-86. PubMed ID: 2471563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
